A detailed history of Stone X Group Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Stone X Group Inc. holds 5,912 shares of BSX stock, worth $578,075. This represents 0.03% of its overall portfolio holdings.

Number of Shares
5,912
Previous 5,590 5.76%
Holding current value
$578,075
Previous $564 Million 12.61%
% of portfolio
0.03%
Previous 0.23%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

BUY
$89.7 - $107.41 $28,883 - $34,586
322 Added 5.76%
5,912 $635 Million
Q1 2025

Aug 13, 2025

SELL
$89.38 - $106.18 $22,523 - $26,757
-252 Reduced 4.31%
5,590 $564 Million
Q4 2024

Aug 13, 2025

BUY
$83.62 - $91.5 $488,508 - $534,543
5,842 New
5,842 $522 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $140B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Stone X Group Inc. Portfolio

Follow Stone X Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stone X Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Stone X Group Inc. with notifications on news.